Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Prophase Labs Inc (NQ: PRPH ) 2.660 -0.120 (-4.32%) Streaming Delayed Price Updated: 10:23 AM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,692 Open 2.690 Bid (Size) 2.650 (2) Ask (Size) 2.820 (1) Prev. Close 2.780 Today's Range 2.660 - 2.735 52wk Range 2.040 - 7.480 Shares Outstanding 18,045,209 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q2 2024 August 14, 2024 PRPH stock results show that ProPhase Labs missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace PRPH Stock Earnings: ProPhase Labs Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 PRPH stock results show that ProPhase Labs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Performance YTD -42.67% -42.67% 1 Month -15.02% -15.02% 3 Month -50.09% -50.09% 6 Month -46.37% -46.37% 1 Year -49.33% -49.33% More News Read More PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023 March 15, 2024 Via InvestorPlace Earnings Scheduled For March 15, 2024 March 15, 2024 Via Benzinga ProPhase Labs's Earnings: A Preview March 14, 2024 Via Benzinga ProPhase Labs Earnings Preview November 08, 2023 Via Benzinga Analyst Expectations for ProPhase Labs's Future May 12, 2023 Via Benzinga Recap: ProPhase Labs Q1 Earnings May 11, 2023 Via Benzinga Overview Of Value Stocks In The Healthcare Sector April 10, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday August 29, 2023 Via Benzinga DSS, Inc.'s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer To Aggressively Develop Mutual Fund Business For Eventual Spinoff July 26, 2023 Via Benzinga DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement June 27, 2023 Via News Direct ProPhase Labs Earnings Preview March 27, 2023 Via Benzinga A Look Into Healthcare Sector Value Stocks January 23, 2023 Via Benzinga 5 Value Stocks In The Healthcare Sector January 09, 2023 Via Benzinga ProPhase Labs's Return On Capital Employed Overview December 20, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Friday August 11, 2023 Via Benzinga DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement June 27, 2023 Via TheNewswire.com DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement June 26, 2023 Via Benzinga 5 Value Stocks In The Healthcare Sector December 05, 2022 Via Benzinga Earnings Scheduled For August 10, 2023 August 10, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session June 01, 2023 Via Benzinga 7 Small-Cap Biotech Stocks with Massive Potential April 27, 2023 Via InvestorPlace Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)? March 27, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 11, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
